{"id":"W2600483330","doi":"10.1200/jco.2013.31.15_suppl.2517","title":"A phase I first-in-human study of REGN910 (SAR307746), a fully human and selective angiopoietin-2 (Ang2) monoclonal antibody (MAb), in patients with advanced solid tumor malignancies.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Internal medicine; Adverse effect; Pharmacodynamics; Cancer; Peripheral edema; Gastroenterology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001778243,0.002207148,0.001761181,0.0003738297,0.0004990453,0.0009103158,0.0008708697,0.001204294,0.004012313],"category_scores_gemma":[0.0008019651,0.0007524951,0.001078188,0.0003344746,0.001058526,0.0009912867,0.0004387314,0.003635139,0.001217413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001137267,"about_ca_system_score_gemma":0.001994194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009059164,"about_ca_topic_score_gemma":0.00219721,"domain_scores_codex":[0.9995475,0.0002093255,0.00001621676,0.00007419063,0.0000417468,0.0001110249],"domain_scores_gemma":[0.9993532,0.00009716019,0.0001148221,0.00007097227,0.00004049961,0.0003233294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4086543,0.2495072,0.01214157,0.001318841,0.001591176,0.0013695,0.0009053546,0.006506873,0.1473467,0.0006610129,0.01579648,0.154201],"study_design_scores_gemma":[0.257655,0.7126212,0.01088052,0.00003521703,0.000340643,0.0009543183,0.00008325919,0.001401453,0.009639198,0.0003456198,0.006003828,0.00003982169],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850109,0.00227523,0.001789935,0.0005867808,0.0001447042,0.005186311,0.002334073,0.0001793852,0.002492737],"genre_scores_gemma":[0.9773008,0.002139003,0.003965778,0.001666894,0.0002464993,0.005125632,0.0044533,0.00008659114,0.005015374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004012313,"threshold_uncertainty_score":0.01342255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03159889900067862,"score_gpt":0.4230644155060121,"score_spread":0.3914655165053335,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}